<unk>  is a direct thrombin inhibitor that is FDA approved for the prophylaxis of stroke and systemic embolism in patients with non-valvular atrial fibrillation. There is a Black Box Warning for this drug as shown here. Common adverse reactions include esophagitis, gastritis, gastroesophageal reflux disease, gastrointestinal hemorrhage, gastrointestinal ulcer, indigestion,bleeding.
Dabigatran
Apixaban
Enoxaparin
Iotalamic acid
Ticlopidine
Ticagrelor
Eptifibatide
Oxeladin